Management of Muscle Cramps in Postmenopausal Women
Medication-Induced Muscle Cramps
- Up to 50% of postmenopausal women receiving aromatase inhibitor therapy for breast cancer report myalgias severe enough that 20% discontinue treatment, according to the American Cancer Society 1, 2
- Aromatase inhibitor-associated musculoskeletal symptoms are often not responsive to NSAIDs or acetaminophen, as recommended by the American Cancer Society 1
Nutritional Deficiencies
- Calcium intake below 1200 mg/day may contribute to musculoskeletal symptoms, as suggested by the American Cancer Society 1
Pain and Disability-Related Factors
- Chronic musculoskeletal pain conditions common in postmenopausal women often coexist with cramping, according to the American Cancer Society 1, 2
Clinical Assessment Approach
- Current medications, specifically aromatase inhibitors, tamoxifen, or other hormonal therapies, should be reviewed, as recommended by the American Cancer Society 1
- Dietary intake of calcium, vitamin D, and potassium should be assessed, according to the American Cancer Society 1
Management Strategy
- Physical activity and regular weight-bearing exercise are essential, as recommended by the American Cancer Society 1
- Acupuncture has demonstrated statistically significant improvement in aromatase inhibitor-associated symptoms, according to the American Cancer Society 1, 2
- Calcium supplementation to achieve total intake of 1200 mg/day is recommended, as suggested by the American Cancer Society 1
- Vitamin D3 supplementation 600-1000 IU/day for all women over 50 years is recommended, according to the American Cancer Society 1
Important Clinical Pitfalls
- Medication review should not be overlooked, as aromatase inhibitors are a leading iatrogenic cause that requires specific management, as recommended by the American Cancer Society 1
- Avoiding tobacco use and limiting alcohol intake is recommended, as these worsen musculoskeletal health, according to the American Cancer Society 1